Global CAR T-Cell-Based Drug Market Research Report 2026(Status and Outlook)
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.The CAR T-cell-based drug market is driven by the growing demand for innovative and targeted cancer therapies. Chimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary approach that involves genetically modifying a patient"s T cells to recognize and attack cancer cells. The success of CAR T-cell therapies in treating certain types of blood cancers, such as leukemia and lymphoma, has fueled market growth and encouraged research into expanding the application of CAR T-cell therapy to other solid tumor malignancies. However, the market also faces challenges, including the high cost of CAR T-cell therapy and the complexity of the manufacturing process, which may limit patient access. Additionally, the potential for severe side effects and the need for patient selection and management pose regulatory and clinical challenges. To succeed, companies must focus on advancing research, streamlining the production process, collaborating with healthcare providers to improve patient access and support, and addressing safety and efficacy concerns to establish CAR T-cell-based drugs as a transformative treatment option for cancer patients.
The global CAR T-Cell-Based Drug market size was estimated at USD 5168.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 29.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CAR T-Cell-Based Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CAR T-Cell-Based Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CAR T-Cell-Based Drug market.
Global CAR T-Cell-Based Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Market Segmentation (by Type)
CD19-targeted
BCMA-targeted
Market Segmentation (by Application)
Lymphoma
Multiple Myeloma
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CAR T-Cell-Based Drug Market
Overview of the regional outlook of the CAR T-Cell-Based Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CAR T-Cell-Based Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CAR T-Cell-Based Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global CAR T-Cell-Based Drug market size was estimated at USD 5168.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 29.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CAR T-Cell-Based Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CAR T-Cell-Based Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CAR T-Cell-Based Drug market.
Global CAR T-Cell-Based Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Market Segmentation (by Type)
CD19-targeted
BCMA-targeted
Market Segmentation (by Application)
Lymphoma
Multiple Myeloma
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CAR T-Cell-Based Drug Market
Overview of the regional outlook of the CAR T-Cell-Based Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CAR T-Cell-Based Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CAR T-Cell-Based Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of CAR T-Cell-Based Drug
1.2 Key Market Segments
1.2.1 CAR T-Cell-Based Drug Segment by Type
1.2.2 CAR T-Cell-Based Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CAR T-CELL-BASED DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CAR T-Cell-Based Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global CAR T-Cell-Based Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CAR T-CELL-BASED DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global CAR T-Cell-Based Drug Product Life Cycle
3.3 Global CAR T-Cell-Based Drug Sales by Manufacturers (2020-2025)
3.4 Global CAR T-Cell-Based Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 CAR T-Cell-Based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global CAR T-Cell-Based Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 CAR T-Cell-Based Drug Market Competitive Situation and Trends
3.8.1 CAR T-Cell-Based Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest CAR T-Cell-Based Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CAR T-CELL-BASED DRUG INDUSTRY CHAIN ANALYSIS
4.1 CAR T-Cell-Based Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CAR T-CELL-BASED DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global CAR T-Cell-Based Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to CAR T-Cell-Based Drug Market
5.7 ESG Ratings of Leading Companies
6 CAR T-CELL-BASED DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CAR T-Cell-Based Drug Sales Market Share by Type (2020-2025)
6.3 Global CAR T-Cell-Based Drug Market Size by Type (2020-2025)
6.4 Global CAR T-Cell-Based Drug Price by Type (2020-2025)
7 CAR T-CELL-BASED DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CAR T-Cell-Based Drug Market Sales by Application (2020-2025)
7.3 Global CAR T-Cell-Based Drug Market Size (M USD) by Application (2020-2025)
7.4 Global CAR T-Cell-Based Drug Sales Growth Rate by Application (2020-2025)
8 CAR T-CELL-BASED DRUG MARKET SALES BY REGION
8.1 Global CAR T-Cell-Based Drug Sales by Region
8.1.1 Global CAR T-Cell-Based Drug Sales by Region
8.1.2 Global CAR T-Cell-Based Drug Sales Market Share by Region
8.2 Global CAR T-Cell-Based Drug Market Size by Region
8.2.1 Global CAR T-Cell-Based Drug Market Size by Region
8.2.2 Global CAR T-Cell-Based Drug Market Size by Region
8.3 North America
8.3.1 North America CAR T-Cell-Based Drug Sales by Country
8.3.2 North America CAR T-Cell-Based Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe CAR T-Cell-Based Drug Sales by Country
8.4.2 Europe CAR T-Cell-Based Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific CAR T-Cell-Based Drug Sales by Region
8.5.2 Asia Pacific CAR T-Cell-Based Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America CAR T-Cell-Based Drug Sales by Country
8.6.2 South America CAR T-Cell-Based Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa CAR T-Cell-Based Drug Sales by Region
8.7.2 Middle East and Africa CAR T-Cell-Based Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CAR T-CELL-BASED DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of CAR T-Cell-Based Drug by Region(2020-2025)
9.2 Global CAR T-Cell-Based Drug Revenue Market Share by Region (2020-2025)
9.3 Global CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America CAR T-Cell-Based Drug Production
9.4.1 North America CAR T-Cell-Based Drug Production Growth Rate (2020-2025)
9.4.2 North America CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe CAR T-Cell-Based Drug Production
9.5.1 Europe CAR T-Cell-Based Drug Production Growth Rate (2020-2025)
9.5.2 Europe CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan CAR T-Cell-Based Drug Production (2020-2025)
9.6.1 Japan CAR T-Cell-Based Drug Production Growth Rate (2020-2025)
9.6.2 Japan CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China CAR T-Cell-Based Drug Production (2020-2025)
9.7.1 China CAR T-Cell-Based Drug Production Growth Rate (2020-2025)
9.7.2 China CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis CAR T-Cell-Based Drug Product Overview
10.1.3 Novartis CAR T-Cell-Based Drug Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Gilead Sciences
10.2.1 Gilead Sciences Basic Information
10.2.2 Gilead Sciences CAR T-Cell-Based Drug Product Overview
10.2.3 Gilead Sciences CAR T-Cell-Based Drug Product Market Performance
10.2.4 Gilead Sciences Business Overview
10.2.5 Gilead Sciences SWOT Analysis
10.2.6 Gilead Sciences Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Basic Information
10.3.2 Bristol-Myers Squibb CAR T-Cell-Based Drug Product Overview
10.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Product Market Performance
10.3.4 Bristol-Myers Squibb Business Overview
10.3.5 Bristol-Myers Squibb SWOT Analysis
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 J and J
10.4.1 J and J Basic Information
10.4.2 J and J CAR T-Cell-Based Drug Product Overview
10.4.3 J and J CAR T-Cell-Based Drug Product Market Performance
10.4.4 J and J Business Overview
10.4.5 J and J Recent Developments
10.5 JW Therapeutics
10.5.1 JW Therapeutics Basic Information
10.5.2 JW Therapeutics CAR T-Cell-Based Drug Product Overview
10.5.3 JW Therapeutics CAR T-Cell-Based Drug Product Market Performance
10.5.4 JW Therapeutics Business Overview
10.5.5 JW Therapeutics Recent Developments
10.6 FOSUNKite
10.6.1 FOSUNKite Basic Information
10.6.2 FOSUNKite CAR T-Cell-Based Drug Product Overview
10.6.3 FOSUNKite CAR T-Cell-Based Drug Product Market Performance
10.6.4 FOSUNKite Business Overview
10.6.5 FOSUNKite Recent Developments
10.7 CARsgen Therapeutics
10.7.1 CARsgen Therapeutics Basic Information
10.7.2 CARsgen Therapeutics CAR T-Cell-Based Drug Product Overview
10.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Product Market Performance
10.7.4 CARsgen Therapeutics Business Overview
10.7.5 CARsgen Therapeutics Recent Developments
10.8 Autolus Therapeutics
10.8.1 Autolus Therapeutics Basic Information
10.8.2 Autolus Therapeutics CAR T-Cell-Based Drug Product Overview
10.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Product Market Performance
10.8.4 Autolus Therapeutics Business Overview
10.8.5 Autolus Therapeutics Recent Developments
10.9 Sorrento Therapeutics
10.9.1 Sorrento Therapeutics Basic Information
10.9.2 Sorrento Therapeutics CAR T-Cell-Based Drug Product Overview
10.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Product Market Performance
10.9.4 Sorrento Therapeutics Business Overview
10.9.5 Sorrento Therapeutics Recent Developments
10.10 Mustang Bio
10.10.1 Mustang Bio Basic Information
10.10.2 Mustang Bio CAR T-Cell-Based Drug Product Overview
10.10.3 Mustang Bio CAR T-Cell-Based Drug Product Market Performance
10.10.4 Mustang Bio Business Overview
10.10.5 Mustang Bio Recent Developments
10.11 Bluebird Bio
10.11.1 Bluebird Bio Basic Information
10.11.2 Bluebird Bio CAR T-Cell-Based Drug Product Overview
10.11.3 Bluebird Bio CAR T-Cell-Based Drug Product Market Performance
10.11.4 Bluebird Bio Business Overview
10.11.5 Bluebird Bio Recent Developments
10.12 Cellectis
10.12.1 Cellectis Basic Information
10.12.2 Cellectis CAR T-Cell-Based Drug Product Overview
10.12.3 Cellectis CAR T-Cell-Based Drug Product Market Performance
10.12.4 Cellectis Business Overview
10.12.5 Cellectis Recent Developments
10.13 Allogene Therapeutics
10.13.1 Allogene Therapeutics Basic Information
10.13.2 Allogene Therapeutics CAR T-Cell-Based Drug Product Overview
10.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Product Market Performance
10.13.4 Allogene Therapeutics Business Overview
10.13.5 Allogene Therapeutics Recent Developments
10.14 Celyad
10.14.1 Celyad Basic Information
10.14.2 Celyad CAR T-Cell-Based Drug Product Overview
10.14.3 Celyad CAR T-Cell-Based Drug Product Market Performance
10.14.4 Celyad Business Overview
10.14.5 Celyad Recent Developments
11 CAR T-CELL-BASED DRUG MARKET FORECAST BY REGION
11.1 Global CAR T-Cell-Based Drug Market Size Forecast
11.2 Global CAR T-Cell-Based Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe CAR T-Cell-Based Drug Market Size Forecast by Country
11.2.3 Asia Pacific CAR T-Cell-Based Drug Market Size Forecast by Region
11.2.4 South America CAR T-Cell-Based Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of CAR T-Cell-Based Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global CAR T-Cell-Based Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of CAR T-Cell-Based Drug by Type (2026-2035)
12.1.2 Global CAR T-Cell-Based Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of CAR T-Cell-Based Drug by Type (2026-2035)
12.2 Global CAR T-Cell-Based Drug Market Forecast by Application (2026-2035)
12.2.1 Global CAR T-Cell-Based Drug Sales (K MT) Forecast by Application
12.2.2 Global CAR T-Cell-Based Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of CAR T-Cell-Based Drug
1.2 Key Market Segments
1.2.1 CAR T-Cell-Based Drug Segment by Type
1.2.2 CAR T-Cell-Based Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CAR T-CELL-BASED DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CAR T-Cell-Based Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global CAR T-Cell-Based Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CAR T-CELL-BASED DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global CAR T-Cell-Based Drug Product Life Cycle
3.3 Global CAR T-Cell-Based Drug Sales by Manufacturers (2020-2025)
3.4 Global CAR T-Cell-Based Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 CAR T-Cell-Based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global CAR T-Cell-Based Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 CAR T-Cell-Based Drug Market Competitive Situation and Trends
3.8.1 CAR T-Cell-Based Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest CAR T-Cell-Based Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CAR T-CELL-BASED DRUG INDUSTRY CHAIN ANALYSIS
4.1 CAR T-Cell-Based Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CAR T-CELL-BASED DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global CAR T-Cell-Based Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to CAR T-Cell-Based Drug Market
5.7 ESG Ratings of Leading Companies
6 CAR T-CELL-BASED DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CAR T-Cell-Based Drug Sales Market Share by Type (2020-2025)
6.3 Global CAR T-Cell-Based Drug Market Size by Type (2020-2025)
6.4 Global CAR T-Cell-Based Drug Price by Type (2020-2025)
7 CAR T-CELL-BASED DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CAR T-Cell-Based Drug Market Sales by Application (2020-2025)
7.3 Global CAR T-Cell-Based Drug Market Size (M USD) by Application (2020-2025)
7.4 Global CAR T-Cell-Based Drug Sales Growth Rate by Application (2020-2025)
8 CAR T-CELL-BASED DRUG MARKET SALES BY REGION
8.1 Global CAR T-Cell-Based Drug Sales by Region
8.1.1 Global CAR T-Cell-Based Drug Sales by Region
8.1.2 Global CAR T-Cell-Based Drug Sales Market Share by Region
8.2 Global CAR T-Cell-Based Drug Market Size by Region
8.2.1 Global CAR T-Cell-Based Drug Market Size by Region
8.2.2 Global CAR T-Cell-Based Drug Market Size by Region
8.3 North America
8.3.1 North America CAR T-Cell-Based Drug Sales by Country
8.3.2 North America CAR T-Cell-Based Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe CAR T-Cell-Based Drug Sales by Country
8.4.2 Europe CAR T-Cell-Based Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific CAR T-Cell-Based Drug Sales by Region
8.5.2 Asia Pacific CAR T-Cell-Based Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America CAR T-Cell-Based Drug Sales by Country
8.6.2 South America CAR T-Cell-Based Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa CAR T-Cell-Based Drug Sales by Region
8.7.2 Middle East and Africa CAR T-Cell-Based Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CAR T-CELL-BASED DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of CAR T-Cell-Based Drug by Region(2020-2025)
9.2 Global CAR T-Cell-Based Drug Revenue Market Share by Region (2020-2025)
9.3 Global CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America CAR T-Cell-Based Drug Production
9.4.1 North America CAR T-Cell-Based Drug Production Growth Rate (2020-2025)
9.4.2 North America CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe CAR T-Cell-Based Drug Production
9.5.1 Europe CAR T-Cell-Based Drug Production Growth Rate (2020-2025)
9.5.2 Europe CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan CAR T-Cell-Based Drug Production (2020-2025)
9.6.1 Japan CAR T-Cell-Based Drug Production Growth Rate (2020-2025)
9.6.2 Japan CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China CAR T-Cell-Based Drug Production (2020-2025)
9.7.1 China CAR T-Cell-Based Drug Production Growth Rate (2020-2025)
9.7.2 China CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis CAR T-Cell-Based Drug Product Overview
10.1.3 Novartis CAR T-Cell-Based Drug Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Gilead Sciences
10.2.1 Gilead Sciences Basic Information
10.2.2 Gilead Sciences CAR T-Cell-Based Drug Product Overview
10.2.3 Gilead Sciences CAR T-Cell-Based Drug Product Market Performance
10.2.4 Gilead Sciences Business Overview
10.2.5 Gilead Sciences SWOT Analysis
10.2.6 Gilead Sciences Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Basic Information
10.3.2 Bristol-Myers Squibb CAR T-Cell-Based Drug Product Overview
10.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Product Market Performance
10.3.4 Bristol-Myers Squibb Business Overview
10.3.5 Bristol-Myers Squibb SWOT Analysis
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 J and J
10.4.1 J and J Basic Information
10.4.2 J and J CAR T-Cell-Based Drug Product Overview
10.4.3 J and J CAR T-Cell-Based Drug Product Market Performance
10.4.4 J and J Business Overview
10.4.5 J and J Recent Developments
10.5 JW Therapeutics
10.5.1 JW Therapeutics Basic Information
10.5.2 JW Therapeutics CAR T-Cell-Based Drug Product Overview
10.5.3 JW Therapeutics CAR T-Cell-Based Drug Product Market Performance
10.5.4 JW Therapeutics Business Overview
10.5.5 JW Therapeutics Recent Developments
10.6 FOSUNKite
10.6.1 FOSUNKite Basic Information
10.6.2 FOSUNKite CAR T-Cell-Based Drug Product Overview
10.6.3 FOSUNKite CAR T-Cell-Based Drug Product Market Performance
10.6.4 FOSUNKite Business Overview
10.6.5 FOSUNKite Recent Developments
10.7 CARsgen Therapeutics
10.7.1 CARsgen Therapeutics Basic Information
10.7.2 CARsgen Therapeutics CAR T-Cell-Based Drug Product Overview
10.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Product Market Performance
10.7.4 CARsgen Therapeutics Business Overview
10.7.5 CARsgen Therapeutics Recent Developments
10.8 Autolus Therapeutics
10.8.1 Autolus Therapeutics Basic Information
10.8.2 Autolus Therapeutics CAR T-Cell-Based Drug Product Overview
10.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Product Market Performance
10.8.4 Autolus Therapeutics Business Overview
10.8.5 Autolus Therapeutics Recent Developments
10.9 Sorrento Therapeutics
10.9.1 Sorrento Therapeutics Basic Information
10.9.2 Sorrento Therapeutics CAR T-Cell-Based Drug Product Overview
10.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Product Market Performance
10.9.4 Sorrento Therapeutics Business Overview
10.9.5 Sorrento Therapeutics Recent Developments
10.10 Mustang Bio
10.10.1 Mustang Bio Basic Information
10.10.2 Mustang Bio CAR T-Cell-Based Drug Product Overview
10.10.3 Mustang Bio CAR T-Cell-Based Drug Product Market Performance
10.10.4 Mustang Bio Business Overview
10.10.5 Mustang Bio Recent Developments
10.11 Bluebird Bio
10.11.1 Bluebird Bio Basic Information
10.11.2 Bluebird Bio CAR T-Cell-Based Drug Product Overview
10.11.3 Bluebird Bio CAR T-Cell-Based Drug Product Market Performance
10.11.4 Bluebird Bio Business Overview
10.11.5 Bluebird Bio Recent Developments
10.12 Cellectis
10.12.1 Cellectis Basic Information
10.12.2 Cellectis CAR T-Cell-Based Drug Product Overview
10.12.3 Cellectis CAR T-Cell-Based Drug Product Market Performance
10.12.4 Cellectis Business Overview
10.12.5 Cellectis Recent Developments
10.13 Allogene Therapeutics
10.13.1 Allogene Therapeutics Basic Information
10.13.2 Allogene Therapeutics CAR T-Cell-Based Drug Product Overview
10.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Product Market Performance
10.13.4 Allogene Therapeutics Business Overview
10.13.5 Allogene Therapeutics Recent Developments
10.14 Celyad
10.14.1 Celyad Basic Information
10.14.2 Celyad CAR T-Cell-Based Drug Product Overview
10.14.3 Celyad CAR T-Cell-Based Drug Product Market Performance
10.14.4 Celyad Business Overview
10.14.5 Celyad Recent Developments
11 CAR T-CELL-BASED DRUG MARKET FORECAST BY REGION
11.1 Global CAR T-Cell-Based Drug Market Size Forecast
11.2 Global CAR T-Cell-Based Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe CAR T-Cell-Based Drug Market Size Forecast by Country
11.2.3 Asia Pacific CAR T-Cell-Based Drug Market Size Forecast by Region
11.2.4 South America CAR T-Cell-Based Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of CAR T-Cell-Based Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global CAR T-Cell-Based Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of CAR T-Cell-Based Drug by Type (2026-2035)
12.1.2 Global CAR T-Cell-Based Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of CAR T-Cell-Based Drug by Type (2026-2035)
12.2 Global CAR T-Cell-Based Drug Market Forecast by Application (2026-2035)
12.2.1 Global CAR T-Cell-Based Drug Sales (K MT) Forecast by Application
12.2.2 Global CAR T-Cell-Based Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global CAR T-Cell-Based Drug Market Size by Type (M USD)
Table 4. Global CAR T-Cell-Based Drug Market Size by Application
Table 5. CAR T-Cell-Based Drug Market Size Comparison by Region (M USD)
Table 6. Global CAR T-Cell-Based Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global CAR T-Cell-Based Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global CAR T-Cell-Based Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global CAR T-Cell-Based Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell-Based Drug as of 2025)
Table 11. Global Market CAR T-Cell-Based Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global CAR T-Cell-Based Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CAR T-Cell-Based Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global CAR T-Cell-Based Drug Sales by Type (K MT)
Table 27. Global CAR T-Cell-Based Drug Market Size by Type (M USD)
Table 28. Global CAR T-Cell-Based Drug Sales (K MT) by Type (2020-2025)
Table 29. Global CAR T-Cell-Based Drug Sales Market Share by Type (2020-2025)
Table 30. Global CAR T-Cell-Based Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global CAR T-Cell-Based Drug Market Share by Type (2020-2025)
Table 32. Global CAR T-Cell-Based Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global CAR T-Cell-Based Drug Sales (K MT) by Application
Table 34. Global CAR T-Cell-Based Drug Market Size by Application
Table 35. Global CAR T-Cell-Based Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global CAR T-Cell-Based Drug Sales Market Share by Application (2020-2025)
Table 37. Global CAR T-Cell-Based Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global CAR T-Cell-Based Drug Market Share by Application (2020-2025)
Table 39. Global CAR T-Cell-Based Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global CAR T-Cell-Based Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global CAR T-Cell-Based Drug Sales Market Share by Region (2020-2025)
Table 42. Global CAR T-Cell-Based Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global CAR T-Cell-Based Drug Market Size by Region (2020-2025)
Table 44. North America CAR T-Cell-Based Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America CAR T-Cell-Based Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe CAR T-Cell-Based Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe CAR T-Cell-Based Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific CAR T-Cell-Based Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific CAR T-Cell-Based Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America CAR T-Cell-Based Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America CAR T-Cell-Based Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa CAR T-Cell-Based Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa CAR T-Cell-Based Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global CAR T-Cell-Based Drug Production (K MT) by Region(2020-2025)
Table 55. Global CAR T-Cell-Based Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global CAR T-Cell-Based Drug Revenue Market Share by Region (2020-2025)
Table 57. Global CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis CAR T-Cell-Based Drug Product Overview
Table 64. Novartis CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Gilead Sciences Basic Information
Table 69. Gilead Sciences CAR T-Cell-Based Drug Product Overview
Table 70. Gilead Sciences CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Gilead Sciences Business Overview
Table 72. Gilead Sciences SWOT Analysis
Table 73. Gilead Sciences Recent Developments
Table 74. Bristol-Myers Squibb Basic Information
Table 75. Bristol-Myers Squibb CAR T-Cell-Based Drug Product Overview
Table 76. Bristol-Myers Squibb CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb SWOT Analysis
Table 79. Bristol-Myers Squibb Recent Developments
Table 80. J and J Basic Information
Table 81. J and J CAR T-Cell-Based Drug Product Overview
Table 82. J and J CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. J and J Business Overview
Table 84. J and J Recent Developments
Table 85. JW Therapeutics Basic Information
Table 86. JW Therapeutics CAR T-Cell-Based Drug Product Overview
Table 87. JW Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. JW Therapeutics Business Overview
Table 89. JW Therapeutics Recent Developments
Table 90. FOSUNKite Basic Information
Table 91. FOSUNKite CAR T-Cell-Based Drug Product Overview
Table 92. FOSUNKite CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. FOSUNKite Business Overview
Table 94. FOSUNKite Recent Developments
Table 95. CARsgen Therapeutics Basic Information
Table 96. CARsgen Therapeutics CAR T-Cell-Based Drug Product Overview
Table 97. CARsgen Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. CARsgen Therapeutics Business Overview
Table 99. CARsgen Therapeutics Recent Developments
Table 100. Autolus Therapeutics Basic Information
Table 101. Autolus Therapeutics CAR T-Cell-Based Drug Product Overview
Table 102. Autolus Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Autolus Therapeutics Business Overview
Table 104. Autolus Therapeutics Recent Developments
Table 105. Sorrento Therapeutics Basic Information
Table 106. Sorrento Therapeutics CAR T-Cell-Based Drug Product Overview
Table 107. Sorrento Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sorrento Therapeutics Business Overview
Table 109. Sorrento Therapeutics Recent Developments
Table 110. Mustang Bio Basic Information
Table 111. Mustang Bio CAR T-Cell-Based Drug Product Overview
Table 112. Mustang Bio CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Mustang Bio Business Overview
Table 114. Mustang Bio Recent Developments
Table 115. Bluebird Bio Basic Information
Table 116. Bluebird Bio CAR T-Cell-Based Drug Product Overview
Table 117. Bluebird Bio CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Bluebird Bio Business Overview
Table 119. Bluebird Bio Recent Developments
Table 120. Cellectis Basic Information
Table 121. Cellectis CAR T-Cell-Based Drug Product Overview
Table 122. Cellectis CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Cellectis Business Overview
Table 124. Cellectis Recent Developments
Table 125. Allogene Therapeutics Basic Information
Table 126. Allogene Therapeutics CAR T-Cell-Based Drug Product Overview
Table 127. Allogene Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Allogene Therapeutics Business Overview
Table 129. Allogene Therapeutics Recent Developments
Table 130. Celyad Basic Information
Table 131. Celyad CAR T-Cell-Based Drug Product Overview
Table 132. Celyad CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Celyad Business Overview
Table 134. Celyad Recent Developments
Table 135. Global CAR T-Cell-Based Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global CAR T-Cell-Based Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America CAR T-Cell-Based Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America CAR T-Cell-Based Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe CAR T-Cell-Based Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe CAR T-Cell-Based Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific CAR T-Cell-Based Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific CAR T-Cell-Based Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America CAR T-Cell-Based Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America CAR T-Cell-Based Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa CAR T-Cell-Based Drug Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa CAR T-Cell-Based Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global CAR T-Cell-Based Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global CAR T-Cell-Based Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global CAR T-Cell-Based Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global CAR T-Cell-Based Drug Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global CAR T-Cell-Based Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global CAR T-Cell-Based Drug Market Size by Type (M USD)
Table 4. Global CAR T-Cell-Based Drug Market Size by Application
Table 5. CAR T-Cell-Based Drug Market Size Comparison by Region (M USD)
Table 6. Global CAR T-Cell-Based Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global CAR T-Cell-Based Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global CAR T-Cell-Based Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global CAR T-Cell-Based Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell-Based Drug as of 2025)
Table 11. Global Market CAR T-Cell-Based Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global CAR T-Cell-Based Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CAR T-Cell-Based Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global CAR T-Cell-Based Drug Sales by Type (K MT)
Table 27. Global CAR T-Cell-Based Drug Market Size by Type (M USD)
Table 28. Global CAR T-Cell-Based Drug Sales (K MT) by Type (2020-2025)
Table 29. Global CAR T-Cell-Based Drug Sales Market Share by Type (2020-2025)
Table 30. Global CAR T-Cell-Based Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global CAR T-Cell-Based Drug Market Share by Type (2020-2025)
Table 32. Global CAR T-Cell-Based Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global CAR T-Cell-Based Drug Sales (K MT) by Application
Table 34. Global CAR T-Cell-Based Drug Market Size by Application
Table 35. Global CAR T-Cell-Based Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global CAR T-Cell-Based Drug Sales Market Share by Application (2020-2025)
Table 37. Global CAR T-Cell-Based Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global CAR T-Cell-Based Drug Market Share by Application (2020-2025)
Table 39. Global CAR T-Cell-Based Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global CAR T-Cell-Based Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global CAR T-Cell-Based Drug Sales Market Share by Region (2020-2025)
Table 42. Global CAR T-Cell-Based Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global CAR T-Cell-Based Drug Market Size by Region (2020-2025)
Table 44. North America CAR T-Cell-Based Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America CAR T-Cell-Based Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe CAR T-Cell-Based Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe CAR T-Cell-Based Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific CAR T-Cell-Based Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific CAR T-Cell-Based Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America CAR T-Cell-Based Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America CAR T-Cell-Based Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa CAR T-Cell-Based Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa CAR T-Cell-Based Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global CAR T-Cell-Based Drug Production (K MT) by Region(2020-2025)
Table 55. Global CAR T-Cell-Based Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global CAR T-Cell-Based Drug Revenue Market Share by Region (2020-2025)
Table 57. Global CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis CAR T-Cell-Based Drug Product Overview
Table 64. Novartis CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Gilead Sciences Basic Information
Table 69. Gilead Sciences CAR T-Cell-Based Drug Product Overview
Table 70. Gilead Sciences CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Gilead Sciences Business Overview
Table 72. Gilead Sciences SWOT Analysis
Table 73. Gilead Sciences Recent Developments
Table 74. Bristol-Myers Squibb Basic Information
Table 75. Bristol-Myers Squibb CAR T-Cell-Based Drug Product Overview
Table 76. Bristol-Myers Squibb CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb SWOT Analysis
Table 79. Bristol-Myers Squibb Recent Developments
Table 80. J and J Basic Information
Table 81. J and J CAR T-Cell-Based Drug Product Overview
Table 82. J and J CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. J and J Business Overview
Table 84. J and J Recent Developments
Table 85. JW Therapeutics Basic Information
Table 86. JW Therapeutics CAR T-Cell-Based Drug Product Overview
Table 87. JW Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. JW Therapeutics Business Overview
Table 89. JW Therapeutics Recent Developments
Table 90. FOSUNKite Basic Information
Table 91. FOSUNKite CAR T-Cell-Based Drug Product Overview
Table 92. FOSUNKite CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. FOSUNKite Business Overview
Table 94. FOSUNKite Recent Developments
Table 95. CARsgen Therapeutics Basic Information
Table 96. CARsgen Therapeutics CAR T-Cell-Based Drug Product Overview
Table 97. CARsgen Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. CARsgen Therapeutics Business Overview
Table 99. CARsgen Therapeutics Recent Developments
Table 100. Autolus Therapeutics Basic Information
Table 101. Autolus Therapeutics CAR T-Cell-Based Drug Product Overview
Table 102. Autolus Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Autolus Therapeutics Business Overview
Table 104. Autolus Therapeutics Recent Developments
Table 105. Sorrento Therapeutics Basic Information
Table 106. Sorrento Therapeutics CAR T-Cell-Based Drug Product Overview
Table 107. Sorrento Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sorrento Therapeutics Business Overview
Table 109. Sorrento Therapeutics Recent Developments
Table 110. Mustang Bio Basic Information
Table 111. Mustang Bio CAR T-Cell-Based Drug Product Overview
Table 112. Mustang Bio CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Mustang Bio Business Overview
Table 114. Mustang Bio Recent Developments
Table 115. Bluebird Bio Basic Information
Table 116. Bluebird Bio CAR T-Cell-Based Drug Product Overview
Table 117. Bluebird Bio CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Bluebird Bio Business Overview
Table 119. Bluebird Bio Recent Developments
Table 120. Cellectis Basic Information
Table 121. Cellectis CAR T-Cell-Based Drug Product Overview
Table 122. Cellectis CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Cellectis Business Overview
Table 124. Cellectis Recent Developments
Table 125. Allogene Therapeutics Basic Information
Table 126. Allogene Therapeutics CAR T-Cell-Based Drug Product Overview
Table 127. Allogene Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Allogene Therapeutics Business Overview
Table 129. Allogene Therapeutics Recent Developments
Table 130. Celyad Basic Information
Table 131. Celyad CAR T-Cell-Based Drug Product Overview
Table 132. Celyad CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Celyad Business Overview
Table 134. Celyad Recent Developments
Table 135. Global CAR T-Cell-Based Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global CAR T-Cell-Based Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America CAR T-Cell-Based Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America CAR T-Cell-Based Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe CAR T-Cell-Based Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe CAR T-Cell-Based Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific CAR T-Cell-Based Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific CAR T-Cell-Based Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America CAR T-Cell-Based Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America CAR T-Cell-Based Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa CAR T-Cell-Based Drug Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa CAR T-Cell-Based Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global CAR T-Cell-Based Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global CAR T-Cell-Based Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global CAR T-Cell-Based Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global CAR T-Cell-Based Drug Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global CAR T-Cell-Based Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of CAR T-Cell-Based Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CAR T-Cell-Based Drug Market Size (M USD), 2025-2035
Figure 5. Global CAR T-Cell-Based Drug Market Size (M USD) (2020-2035)
Figure 6. Global CAR T-Cell-Based Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CAR T-Cell-Based Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global CAR T-Cell-Based Drug Product Life Cycle
Figure 13. CAR T-Cell-Based Drug Sales Share by Manufacturers in 2025
Figure 14. Global CAR T-Cell-Based Drug Revenue Share by Manufacturers in 2025
Figure 15. CAR T-Cell-Based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market CAR T-Cell-Based Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by CAR T-Cell-Based Drug Revenue in 2025
Figure 18. Industry Chain Map of CAR T-Cell-Based Drug
Figure 19. Global CAR T-Cell-Based Drug Market PEST Analysis
Figure 20. Global CAR T-Cell-Based Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global CAR T-Cell-Based Drug Market Share by Type
Figure 27. Sales Market Share of CAR T-Cell-Based Drug by Type (2020-2025)
Figure 28. Sales Market Share of CAR T-Cell-Based Drug by Type in 2025
Figure 29. Market Share of CAR T-Cell-Based Drug by Type (2020-2025)
Figure 30. Market Share of CAR T-Cell-Based Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global CAR T-Cell-Based Drug Market Share by Application
Figure 33. Global CAR T-Cell-Based Drug Sales Market Share by Application (2020-2025)
Figure 34. Global CAR T-Cell-Based Drug Sales Market Share by Application in 2025
Figure 35. Global CAR T-Cell-Based Drug Market Share by Application (2020-2025)
Figure 36. Global CAR T-Cell-Based Drug Market Share by Application in 2025
Figure 37. Global CAR T-Cell-Based Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global CAR T-Cell-Based Drug Sales Market Share by Region (2020-2025)
Figure 39. Global CAR T-Cell-Based Drug Market Size by Region (2020-2025)
Figure 40. North America CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America CAR T-Cell-Based Drug Sales Market Share by Country in 2024
Figure 43. North America CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America CAR T-Cell-Based Drug Market Size by Country in 2024
Figure 45. U.S. CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada CAR T-Cell-Based Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada CAR T-Cell-Based Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico CAR T-Cell-Based Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico CAR T-Cell-Based Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe CAR T-Cell-Based Drug Sales Market Share by Country in 2024
Figure 53. Europe CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe CAR T-Cell-Based Drug Market Size by Country in 2024
Figure 55. Germany CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific CAR T-Cell-Based Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific CAR T-Cell-Based Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific CAR T-Cell-Based Drug Market Size by Region in 2024
Figure 68. China CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America CAR T-Cell-Based Drug Sales and Growth Rate (K MT)
Figure 79. South America CAR T-Cell-Based Drug Sales Market Share by Country in 2024
Figure 80. South America CAR T-Cell-Based Drug Market Size and Growth Rate (M USD)
Figure 81. South America CAR T-Cell-Based Drug Market Size by Country in 2024
Figure 82. Brazil CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa CAR T-Cell-Based Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa CAR T-Cell-Based Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa CAR T-Cell-Based Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa CAR T-Cell-Based Drug Market Size by Region in 2024
Figure 92. Saudi Arabia CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global CAR T-Cell-Based Drug Production Market Share by Region (2020-2025)
Figure 103. North America CAR T-Cell-Based Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe CAR T-Cell-Based Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan CAR T-Cell-Based Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China CAR T-Cell-Based Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global CAR T-Cell-Based Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global CAR T-Cell-Based Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global CAR T-Cell-Based Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global CAR T-Cell-Based Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global CAR T-Cell-Based Drug Sales Forecast by Application (2026-2035)
Figure 112. Global CAR T-Cell-Based Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of CAR T-Cell-Based Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CAR T-Cell-Based Drug Market Size (M USD), 2025-2035
Figure 5. Global CAR T-Cell-Based Drug Market Size (M USD) (2020-2035)
Figure 6. Global CAR T-Cell-Based Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CAR T-Cell-Based Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global CAR T-Cell-Based Drug Product Life Cycle
Figure 13. CAR T-Cell-Based Drug Sales Share by Manufacturers in 2025
Figure 14. Global CAR T-Cell-Based Drug Revenue Share by Manufacturers in 2025
Figure 15. CAR T-Cell-Based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market CAR T-Cell-Based Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by CAR T-Cell-Based Drug Revenue in 2025
Figure 18. Industry Chain Map of CAR T-Cell-Based Drug
Figure 19. Global CAR T-Cell-Based Drug Market PEST Analysis
Figure 20. Global CAR T-Cell-Based Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global CAR T-Cell-Based Drug Market Share by Type
Figure 27. Sales Market Share of CAR T-Cell-Based Drug by Type (2020-2025)
Figure 28. Sales Market Share of CAR T-Cell-Based Drug by Type in 2025
Figure 29. Market Share of CAR T-Cell-Based Drug by Type (2020-2025)
Figure 30. Market Share of CAR T-Cell-Based Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global CAR T-Cell-Based Drug Market Share by Application
Figure 33. Global CAR T-Cell-Based Drug Sales Market Share by Application (2020-2025)
Figure 34. Global CAR T-Cell-Based Drug Sales Market Share by Application in 2025
Figure 35. Global CAR T-Cell-Based Drug Market Share by Application (2020-2025)
Figure 36. Global CAR T-Cell-Based Drug Market Share by Application in 2025
Figure 37. Global CAR T-Cell-Based Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global CAR T-Cell-Based Drug Sales Market Share by Region (2020-2025)
Figure 39. Global CAR T-Cell-Based Drug Market Size by Region (2020-2025)
Figure 40. North America CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America CAR T-Cell-Based Drug Sales Market Share by Country in 2024
Figure 43. North America CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America CAR T-Cell-Based Drug Market Size by Country in 2024
Figure 45. U.S. CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada CAR T-Cell-Based Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada CAR T-Cell-Based Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico CAR T-Cell-Based Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico CAR T-Cell-Based Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe CAR T-Cell-Based Drug Sales Market Share by Country in 2024
Figure 53. Europe CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe CAR T-Cell-Based Drug Market Size by Country in 2024
Figure 55. Germany CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific CAR T-Cell-Based Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific CAR T-Cell-Based Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific CAR T-Cell-Based Drug Market Size by Region in 2024
Figure 68. China CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America CAR T-Cell-Based Drug Sales and Growth Rate (K MT)
Figure 79. South America CAR T-Cell-Based Drug Sales Market Share by Country in 2024
Figure 80. South America CAR T-Cell-Based Drug Market Size and Growth Rate (M USD)
Figure 81. South America CAR T-Cell-Based Drug Market Size by Country in 2024
Figure 82. Brazil CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa CAR T-Cell-Based Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa CAR T-Cell-Based Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa CAR T-Cell-Based Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa CAR T-Cell-Based Drug Market Size by Region in 2024
Figure 92. Saudi Arabia CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa CAR T-Cell-Based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa CAR T-Cell-Based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global CAR T-Cell-Based Drug Production Market Share by Region (2020-2025)
Figure 103. North America CAR T-Cell-Based Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe CAR T-Cell-Based Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan CAR T-Cell-Based Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China CAR T-Cell-Based Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global CAR T-Cell-Based Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global CAR T-Cell-Based Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global CAR T-Cell-Based Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global CAR T-Cell-Based Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global CAR T-Cell-Based Drug Sales Forecast by Application (2026-2035)
Figure 112. Global CAR T-Cell-Based Drug Market Share Forecast by Application (2026-2035)
